Ticker Details
Vaxcyte, Inc.
IPO Date:	July 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.64B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.15 | 2.73%
Avg Daily Range (30 D):	$1.25 | 2.43%
Avg Daily Range (90 D):	$1.28 | 2.32%

Institutional Daily Volume
Avg Daily Volume:	.68M
Avg Daily Volume (30 D):	1.3M
Avg Daily Volume (90 D):	1.19M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	4,531
Avg Institutional Trade:	$3.76M
Avg Institutional Trade (30 D):	$5.4M
Avg Institutional Trade (90 D):	$4.28M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$8.12M
Avg Closing Trade (30 D):	$20.3M
Avg Closing Trade (90 D):	$14.78M
Avg Closing Volume:	154.38K

News

May 20, 2026 @ 1:14 PM Pfizer Expands Pneumococcal Vaccine Push With New ... Source: Vandana Singh

Mar 18, 2026 @ 11:34 PM Positive VAX-31 Phase 1/2 Adult Data Published in ... Source: Vaxcyte, Inc.

Feb 2, 2026 @ 9:05 PM Vaxcyte Announces Closing of $632.5 Million Public... Source: Globe Newswire

Jan 30, 2026 @ 4:33 AM Vaxcyte Announces Pricing of $550 Million Public O... Source: Na

Jan 22, 2026 @ 10:00 PM Vaxcyte Advances Adult and Infant Programs for VAX... Source: Vaxcyte, Inc.

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-2.3	$-1.56
Diluted EPS		$-2.3	$-1.56
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-320.62M	$-212.83M
Operating Income / Loss		$-345.85M	$-242.38M
Cost of Revenue
Net Cash Flow		$86.88M	$-25.52M
PE Ratio